New Releases from NCBI BookshelfAssessing the Safety of Direct-Acting Antivirals for Hepatitis C—A PCORnet Study [Internet].​Assessing the Safety of Direct-Acting Antivirals for Hepatitis C—A PCORnet Study [Internet].

Recent reports based on the US Food and Drug Administration’s voluntary Adverse Events Reporting System raised questions about the safety of direct-acting antivirals (DAAs) for treatment of the hepatitis C virus (HCV).

​